UNITED STATES OF AMERICA
Before the
SECURITIES AND EXCHANGE COMMISSION

SECURITIES EXCHANGE ACT OF 1934
Release No. 77597 / April 13, 2016
ADMINISTRATIVE PROCEEDING
File No. 3-17144

In the Matter of
Map IV Acquisition, Inc.,
Med-Zone Biotechnologies Acquisition,
Inc., and
Millennium Direct, Inc.,

ORDER MAKING FINDINGS AND
REVOKING REGISTRATION OF
SECURITIES PURSUANT TO SECTION 12(j)
OF THE SECURITIES
EXCHANGE ACT OF 1934 AS TO MAP IV
ACQUISITION, INC.

Respondents.

I.
The Securities and Exchange Commission (“Commission”) deems it necessary and
appropriate for the protection of investors to accept the Offer of Settlement submitted by Map IV
Acquisition, Inc. (“Map IV Acquisition” or “Respondent”) pursuant to Rule 240(a) of the Rules of
Practice of the Commission, 17 C.F.R. § 201.240(a), for the purpose of settlement of these
proceedings initiated against Respondent on March 1, 2016, pursuant to Section 12(j) of the
Securities Exchange Act of 1934 (“Exchange Act”).
II.
Solely for the purpose of these proceedings and any other proceedings brought by or on
behalf of the Commission, or to which the Commission is a party, and without admitting or
denying the findings herein, except as to the Commission’s jurisdiction over it and the subject
matter of these proceedings, which are admitted, Respondent consents to the entry of this Order
Making Findings and Revoking Registration of Securities Pursuant to Section 12(j) of the
Securities Exchange Act of 1934 as to Map IV Acquisition, Inc. (“Order”), as set forth below.

III.
On the basis of this Order and Respondent’s Offer, the Commission finds that 1 :
1.
Map IV Acquisition (CIK No. 1393936) is a void Delaware corporation
located in Dix Hills, New York. At all times relevant to this proceeding, the securities of
Map IV Acquisition have been registered under Exchange Act Section 12(g).
2.
Map IV Acquisition has failed to comply with Exchange Act Section 13(a)
and Rules 13a-1 and 13a-13 thereunder because it has not filed any periodic reports with
the Commission since the period ended September 30, 2007.

IV.
In view of the foregoing, the Commission deems it necessary and appropriate for the
protection of investors to impose the sanction specified in Respondent’s Offer.
Accordingly, it is hereby ORDERED that:
Pursuant to Exchange Act Section 12(j), registration of each class of Respondent’s
securities registered pursuant to Exchange Act Section 12 be, and hereby is, revoked.
For the Commission, by its Secretary, pursuant to delegated authority.

Brent J. Fields
Secretary

The findings herein are made pursuant to Respondent’s Offer of Settlement and are not
binding on any other person or entity in this or any other proceeding.
1

